Meningitis claims 6 more lives in Tripura
Agartala: An alarming situation prevails in tribal hamlets in Tripura
Agartala: An alarming situation prevails in tribal hamlets in Tripura
Meningitis is once again weaving a web of death and suffering in India's North-east having taken at least 250 lives so far
AGARTALA, March 18
Agartala: The Centre has finally given a green signal to launch mass vaccination in Tripura
By Sanjib Deb Agartala March 9: Worship of ghosts, an age-old practice which almost went into oblivion, has returned with full fury in the hilly areas of Tripura as the medical care process extended by the state government has failed to contain the meningitis epidemic in the Longthorai Vally areas of Dhalai district.
AGARTALA, March 8
AGARTALA Detection of meningo cuccal meningitis in two patients in the outskirts of Agartala has caused panic as the disease has already took an epidemic form in hilly terrain of Longthorai Vally in Dhalai district and claimed at least 17 lives as per official record, though unofficial sources puts the figure to 51.
new constitution Bolivia reforms land holding Bolivians approved a new constitution granting more power to the country
AGARTALA, Feb 17
AGARTALA
PNS | Shillong Meghalaya Health and Family Welfare Minister Advisor Pariong ordered deployment of surveillance rapid teams across the State with the rising incidents of meningococcal meningitis disease.
RAJU DAS SHILLONG, Jan 13
SHILLONG: Meningococcal meningitis has claimed 193 lives in the State this year and there are public concerns that the killer disease is yet to be wiped out from Meghalaya. Director of Health Services Dr KH Lakiang on Wednesday said only ten meningococcal meningitis deaths had been "medically confirmed" by doctors in government hospitals.
A team of epidemiologists has reported that just one-fifth of the standard meningitis vaccine dose triggers an immune response almost as good as that of the full dose, offering a way to potentially stretch limited supplies.
ecological sciences Bird diversity is anti-viral Greater bird diversity protects humans from a deadly virus known to cause meningitis. The West Nile Virus, usually maintained in a bird-mosquito cycle in nature, can be transmitted to humans through a mosquito bite. Biologists from Washington University recently said most birds are bad reservoirs for the virus and so it fails to further
SHILLONG: Despite the government taking help of experts from Delhi to fight meningococcal meningitis, the virus has remained a headache to the Health Department, claiming the life of one more person on Sunday, taking the toll from the disease to nine in the State.
Crippling epidemics of meningococcal meningitis sweep across Africa with the onset of the dry season and harsh harmattan winds. An affordable, effective vaccine in the works could change that.
In a major break through, a vaccine for meningitis B, caused by bacterial infection, has performed well in a preliminary trial in Britain. Meningitis is inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges. Vaccines are available against meningitis A and C, but none yet exists for meningitis B, the leading cause of bacterial meningitis throughout the world. Annually there are between 20,000-80,000 cases of meningitis B all over the world and of these 10 per cent result in death.
An experimental meningitis vaccine appears to generate more potent immunity than the version now available in young people who suffer most from the disease, researchers reported Monday. Previous research shows the Novartis vaccine, called Menveo, also works in young infants, who are not protected by the current vaccine. BETTER LIFE: Health news and wellness tips "It has a great deal of potential in that age group," says Keith Reisinger, medical director of Primary Physicians Research Inc., the for-profit clinical trials organization that carried out the Novartis study.
An experimental meningitis vaccine appears to generate more potent immunity than the version now available in young people who suffer most from the disease, researchers reported Monday. Previous research shows the Novartis vaccine, called Menveo, also works in young infants, who are not protected by the current vaccine. BETTER LIFE: Health news and wellness tips "It has a great deal of potential in that age group," says Keith Reisinger, medical director of Primary Physicians Research Inc., the for-profit clinical trials organization that carried out the Novartis study.